1. Triple-negative mammary carcinoma in two male dogs
- Author
-
Marília Carneiro de Araújo Machado, Angelo Sementilli, Natália de Melo Ocarino, Claudia H. Cruz, Ludmila R. Moroz, Karine Araújo Damasceno, Rogéria Serakides, and Alessandra Estrela-Lima
- Subjects
Male ,Pathology ,medicine.medical_specialty ,040301 veterinary sciences ,Mammary Neoplasms, Animal ,0403 veterinary science ,Mammary carcinoma ,03 medical and health sciences ,Cytokeratin ,Basal (phylogenetics) ,Dogs ,0302 clinical medicine ,Biomarkers, Tumor ,Carcinoma ,medicine ,Animals ,Mixed tumor ,General Veterinary ,business.industry ,Cancer ,04 agricultural and veterinary sciences ,Sex hormone receptor ,medicine.disease ,Immunohistochemistry ,Gene Expression Regulation, Neoplastic ,Receptors, Estrogen ,030220 oncology & carcinogenesis ,Brief Communications ,Receptors, Progesterone ,business - Abstract
Triple-negative tumors are characterized immunohistochemically by the absence of positivity to sex hormone receptors and to human epidermal growth factor receptor 2. Additionally, they are differentiated into basal-like and non-basal (or null) subtypes, based on the presence of basal cytokeratin expression (CK5/6, 14, and17). Triple-negative subtypes are yet to be characterized in male dogs, to our knowledge. We report herein the clinical and pathologic findings and molecular characterization of carcinoma in the mammary glands of 2 male dogs. Case 1 was diagnosed as a grade II tubulopapillary carcinoma; case 2 was diagnosed as a grade II carcinoma in a mixed tumor. The tumors were characterized phenotypically as triple-negative basal and triple-negative non-basal, respectively.
- Published
- 2020
- Full Text
- View/download PDF